salmeterol xinafoate has been researched along with Cancer of Skin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoshima, Y; Chida, K; Enomoto, N; Fujisawa, T; Hashizume, H; Inui, N; Nakamura, Y; Sato, J; Suda, T; Yokomura, K | 1 |
1 other study(ies) available for salmeterol xinafoate and Cancer of Skin
Article | Year |
---|---|
Management of interleukin-2-induced severe bronchoconstriction.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Inflammatory Agents; Antineoplastic Agents; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Delayed-Action Preparations; Drug Administration Schedule; Female; Fluticasone; Forced Expiratory Volume; Hemangioendothelioma; Humans; Infusions, Intravenous; Injections, Intralesional; Interleukin-2; Male; Middle Aged; Premedication; Salmeterol Xinafoate; Skin Neoplasms | 2007 |